- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
IT
Seven essential tips for corporates venturing into the startup nation
Comment by Adam Salkin, a partner in one of Israel’s leading law firms, Herzog, Fox & Neeman
Mar 17, 2022Corporate venturing increases pace of innovation
Analysis by James Mawson, founder, Global Corporate Venturing and co-author of Transformative Innovation (with Christine Gulbranson)
Mar 17, 2022Daily Deal Round Up: March 16, 2022
Bernstein Management and JBG Smith helped accommodation provider Placemakr raise $90m while crypto custodian Hex Trust netted $88m in a round co-led by Animoca Brands.
Mar 16, 2022ConsenSys collects $450m in series D round
The blockchain technology developer received backing from SoftBank Vision Fund 2, Microsoft and UTA VC in a round more than doubling its valuation to $7bn.
Mar 16, 2022SentinelOne to acquire Attivo
Macnica and Singtel Innov8 are set to exit the cybersecurity technology provider in a $617m cash and stock purchase by SentinelOne.
Mar 16, 2022Deals: March 16, 2022
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mar 16, 2022Kymeta climbs to $84m round
Hanwha Systems was among the participants in the satellite communication technology developer’s latest round, having originally agreeing to invest $30m in late 2020.
Mar 16, 2022Daily Deal Round Up: March 15, 2022
MUFG Innovation Partners contributed to mobility financier Moove's $105m series A2 round while MS&AD and Nationwide helped insurance software developer Socotra raise $50m.
Mar 15, 2022DataGrand processes series C funding
Legend Capital and Sunshine Insurance were among the investors in a $91.1m round for the text recognition software developer.
Mar 15, 2022Daily Deal Round Up: March 14, 2022
SAIC Motor’s Hengxu Capital helped allosteric drug developer Nutshell Therapeutics close a $40m round while cancer therapy developer Impact Therapeutics secured series D1 funding.
Mar 14, 2022Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


